121 related articles for article (PubMed ID: 113880)
21. Selection of treatment for muscle infiltrating transitional cell bladder cancer.
Whitmore WF
Arch Esp Urol; 1990; 43 Suppl 2():219-22. PubMed ID: 2096783
[TBL] [Abstract][Full Text] [Related]
22. Editorial: Bladder cancer. How can we make a difference?
Soloway MS
J Urol; 2003 Nov; 170(5):1781-2. PubMed ID: 14532775
[No Abstract] [Full Text] [Related]
23. Hyperthermic perfusion of the distended urinary bladder in the management of recurrent transitional cell carcinoma.
Ludgate CM; McLean N; Carswell GF; Newsam JE; Pettigrew RT; Tulloch WS
Br J Urol; 1975; 47(7):841-8. PubMed ID: 1222351
[TBL] [Abstract][Full Text] [Related]
24. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?
Weiss C; Wolze C; Engehausen DG; Ott OJ; Krause FS; Schrott KM; Dunst J; Sauer R; Rödel C
J Clin Oncol; 2006 May; 24(15):2318-24. PubMed ID: 16710030
[TBL] [Abstract][Full Text] [Related]
25. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
Pham HT; Soloway MS
Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
[TBL] [Abstract][Full Text] [Related]
26. Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group.
Sell A; Jakobsen A; Nerstrøm B; Sørensen BL; Steven K; Barlebo H
Scand J Urol Nephrol Suppl; 1991; 138():193-201. PubMed ID: 1785004
[TBL] [Abstract][Full Text] [Related]
27. [Hyperthermic therapy of the bladder cancer. III. Clinical studies (author's transl)].
Kubota Y
Nihon Hinyokika Gakkai Zasshi; 1981 Jun; 72(6):742-51. PubMed ID: 6169867
[No Abstract] [Full Text] [Related]
28. Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit.
VanderWalde NA; Chi MT; Hurria A; Galsky MD; Nielsen ME
World J Urol; 2016 Jan; 34(1):3-11. PubMed ID: 26497825
[TBL] [Abstract][Full Text] [Related]
29. [Hyperthermic treatment of the bladder cancer: combined hyperthermic treatment with bleomycin and/or radiation (author's transl)].
Kubota Y; Nishimura R; Takai S; Fukushima S
Nihon Gan Chiryo Gakkai Shi; 1978 Aug; 13(4):394-405. PubMed ID: 81868
[No Abstract] [Full Text] [Related]
30. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
Soloway MS; Lee CT; Steinberg GD; Ghandi AA; Jewett MA
Urol Oncol; 2007; 25(4):338-40. PubMed ID: 17628304
[TBL] [Abstract][Full Text] [Related]
31. [Interdisciplinary strategies for the treatment of bladder cancer].
Bauer W; Lamche M; Schramek P
Wien Med Wochenschr; 2007; 157(7-8):153-6. PubMed ID: 17492411
[TBL] [Abstract][Full Text] [Related]
32. Muscle-invasive bladder tumour: can the bladder be preserved?
Sella A
BJU Int; 2008 Nov; 102(9):1053-4. PubMed ID: 18715247
[No Abstract] [Full Text] [Related]
33. Management of transitional cell carcinoma of the bladder.
Murshidi MS
Arch Esp Urol; 1989 Mar; 42(2):172-5. PubMed ID: 2735783
[TBL] [Abstract][Full Text] [Related]
34. The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy.
Parker WP; Ho PL; Boorjian SA; Melquist JJ; Thapa P; Holzbeierlein JM; Frank I; Kamat AM; Lee EK
World J Urol; 2016 Nov; 34(11):1561-1566. PubMed ID: 26943643
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
Kaushik D; Frank I; Boorjian SA; Cheville JC; Eisenberg MS; Thapa P; Tarrell RF; Thompson RH
Int J Urol; 2015 Jun; 22(6):549-54. PubMed ID: 25761779
[TBL] [Abstract][Full Text] [Related]
36. Effects of hyperthermia on bladder cancer.
Hall RR; Schade RO; Swinney J
Br Med J; 1974 Jun; 2(5919):593-4. PubMed ID: 4833966
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422
[No Abstract] [Full Text] [Related]
38. Bibliography. Current world literature. Oncology: bladder and testis.
Curr Opin Urol; 2000 Sep; 10(5):528-37. PubMed ID: 11005457
[No Abstract] [Full Text] [Related]
39. [Infiltrating cancer of the bladder: can radiochemotherapy be an alternative to cystectomy?].
Chrétien Y; Mejean A; Durdux C; Dufour B; Housset M
J Urol (Paris); 1996; 102(1):3-8. PubMed ID: 8763598
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
Simon SD; Srougi M
Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
